XML 16 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segments of Business and Geographic Areas (Tables)
 6 Months Ended
Jul. 01, 2012
Segment Reporting [Abstract]  
Sales by segment of business
SALES BY SEGMENT OF BUSINESS

 
 
Fiscal Second Quarters Ended
(Dollars in Millions)
 
July 1,
2012
 
July 3,
2011
 
Percent
Change
 
 
 
 
 
 
 
Consumer
 
 
 
 
 
 
United States
 
$
1,313

 
$
1,339

 
(1.9
)%
International
 
2,306

 
2,454

 
(6.0
)
Total
 
3,619

 
3,793

 
(4.6
)
Pharmaceutical
 
 
 
 
 
 
United States
 
3,094

 
3,239

 
(4.5
)
International
 
3,197

 
2,994

 
6.8

Total
 
6,291

 
6,233

 
0.9

Medical Devices & Diagnostics
 
 
 
 
 
 
United States
 
2,953

 
2,869

 
2.9

International
 
3,612

 
3,702

 
(2.4
)
Total
 
6,565

 
6,571

 
(0.1
)
Worldwide
 
 
 
 
 
 
United States
 
7,360

 
7,447

 
(1.2
)
International
 
9,115

 
9,150

 
(0.4
)
Total
 
$
16,475

 
$
16,597

 
(0.7
)%

 
 
 
 
 
 
 
 
 
Fiscal Six Months Ended
(Dollars in Millions)
 
July 1,
2012
 
July 3,
2011
 
Percent
Change
 
 
 
 
 
 
 
Consumer
 
 
 
 
 
 
United States
 
$
2,629

 
$
2,684

 
(2.0
)%
International
 
4,585

 
4,791

 
(4.3
)
Total
 
7,214

 
7,475

 
(3.5
)
Pharmaceutical
 
 
 
 
 
 
United States
 
6,120

 
6,630

 
(7.7
)
International
 
6,304

 
5,662

 
11.3

Total
 
12,424

 
12,292

 
1.1

Medical Devices & Diagnostics
 
 
 
 
 
 
United States
 
5,830

 
5,741

 
1.6

International
 
7,146

 
7,262

 
(1.6
)
Total
 
12,976

 
13,003

 
(0.2
)
Worldwide
 
 
 
 
 
 
United States
 
14,579

 
15,055

 
(3.2
)
International
 
18,035

 
17,715

 
1.8

Total
 
$
32,614

 
$
32,770

 
(0.5
)%
Operating profit by segment of business
OPERATING PROFIT BY SEGMENT OF BUSINESS
 
 
Fiscal Second Quarters Ended
(Dollars in Millions)
 
July 1,
2012
 
July 3,
2011
 
Percent
Change
Consumer (1)
 
$
267

 
$
549

 
(51.4
)%
Pharmaceutical (2)
 
515

 
1,714

 
(70.0
)
Medical Devices & Diagnostics(3)
 
1,875

 
1,275

 
47.1

Segments operating profit
 
2,657

 
3,538

 
(24.9
)
Expense not allocated to segments(4)
 
(622
)
 
(116
)
 
 
Worldwide income before taxes
 
$
2,035

 
$
3,422

 
(40.5
)%

 
 
 
 
 
 
 
 
 
Fiscal Six Months Ended
(Dollars in Millions)
 
July 1, 2012
 
July 3, 2011
 
Percent
Change
Consumer (1)
 
$
729

 
$
1,122

 
(35.0
)%
Pharmaceutical (2)
 
3,106

 
3,923

 
(20.8
)
Medical Devices & Diagnostics (3)
 
3,953

 
3,219

 
22.8

Segments operating profit
 
7,788

 
8,264

 
(5.8
)
Expense not allocated to segments (4)
 
(708
)
 
(332
)
 
 
Worldwide income before taxes
 
$
7,080

 
$
7,932

 
(10.7
)%

(1) Includes intangible asset write-downs of $294 million recorded in the fiscal second quarter and the first fiscal six months of 2012.
(2) Includes litigation expense of $658 million, intangible asset write-downs of $499 million and in-process research and development charges of $429 million recorded in the fiscal second quarter and the first fiscal six months of 2012. Includes litigation expense of $290 million and $540 million recorded in the fiscal second quarter and the first fiscal six months of 2011, respectively.
(3) Includes Synthes integration/transaction costs of $192 million and $223 million recorded in the fiscal second quarter and the first fiscal six months of 2012, respectively. Includes intangible asset write-downs of $146 million recorded in the fiscal second quarter and the first fiscal six months of 2012. Includes restructuring expense of $676 million recorded in the fiscal second quarter and the first fiscal six months of 2011. Includes litigation expense of $25 million and ASRTM Hip related costs of $102 million recorded in the fiscal second quarter of 2011. Includes litigation expense of $36 million and ASRTM Hip related costs of $187 million recorded in the first fiscal six months of 2011.
(4) Amounts not allocated to segments include interest income/(expense), non-controlling interests and general corporate income/expense. Includes currency losses related to the Synthes acquisition of $382 million and $234 million recorded in the fiscal second quarter and the first fiscal six months of 2012, respectively, and litigation expense of $11 million recorded in the fiscal second quarter and the first fiscal six months of 2012, respectively. Includes a currency gain of $102 million related to the Synthes acquisition recorded in the fiscal second quarter and the first fiscal six months of 2011.
Sales by geographic area
SALES BY GEOGRAPHIC AREA
 
 
Fiscal Second Quarters Ended
(Dollars in Millions)
 
July 1, 2012
 
July 3, 2011
 
Percent
Change
United States
 
$
7,360

 
$
7,447

 
(1.2
)%
Europe
 
4,165

 
4,543

 
(8.3
)
Western Hemisphere, excluding U.S.
 
1,728

 
1,543

 
12.0

Asia-Pacific, Africa
 
3,222

 
3,064

 
5.2

Total
 
$
16,475

 
$
16,597

 
(0.7
)%

 
 
 
 
 
 
 
 
 
Fiscal Six Months Ended
(Dollars in Millions)
 
July 1, 2012
 
July 3, 2011
 
Percent
Change
United States
 
$
14,579

 
$
15,055

 
(3.2
)%
Europe
 
8,359

 
8,726

 
(4.2
)
Western Hemisphere, excluding U.S.
 
3,442

 
2,979

 
15.5

Asia-Pacific, Africa
 
6,234

 
6,010

 
3.7

Total
 
$
32,614

 
$
32,770

 
(0.5
)%